View all cases
UPC CoA 646/2025
Jul 11, 2025·EP3536712 · METHODS FOR REDUCING LIPOPROTEIN(A) LEVELS BY ADMINISTERING AN INHIBITOR OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN-9 (PCSK9)
- Case details
- StatusCase Closed (Withdrawn)ActionAppealCategoryMain appeal
- Parties
- Respondents
- Regeneron Pharmaceuticals Inc.Operating co.
Representatives- Niels Hoelder-Carpmaels & Ransford
- Division
- Court of Appeal
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Amgen Inc.Withdrawn2024-02-29
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Rian Kalden | Locked |
| Judge Ingeborg Simonsson | Locked |
| Judge Patricia Rombach | Locked |
| Judge Cornelis Schüller | Locked |
| Judge Rainer Friedrich | Locked |
At the UPC: Amgen Group (19 cases)·Regeneron Pharmaceuticals Inc. (9 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 1 other proceedings
4 other defendants litigating the same or a related patent
UPC CoA 641/2025·UPC CFI 534/2025·UPC CFI 195/2025·CC 24999/2024
Start a free trial to see how each one ended.
More cases: Court of Appeal·2025
Decisions
- —appeal
Summary: permits the withdrawal of the appeal and declares the proceedings closed; declares that there is no need for a cost decision; dismisses the request for reimbursement of Court fees;
Documents
Show all 78 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2026-03-26 | Not public |
| Decision | 2026-03-26 | Not public |
| Decision | 2026-03-26 | Public |
| Receipt | 2026-03-12 | Not public |
| Cover sheet | 2026-03-12 | Not public |
| Document Respondent | 2026-03-12 | Not public |
| Receipt | 2026-03-12 | Not public |
| Cover sheet | 2026-03-12 | Not public |
| Application Appellant | 2026-03-12 | Not public |
| Summons to oral hearing | 2026-03-10 | Not public |